LC Bead® Press Releases

LC Bead® press releases and related news and business articles.

19 Aug 2019

BOSTON SCIENTIFIC CLOSES ACQUISITION OF BTG PLC.

Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE:BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.

7 Sep 2018

BTG plc acquires Novate Medical Ltd.

BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company focused on the prevention of pulmonary embolism (PE) in patients at high risk of venous thromboembolic events.

5 Oct 2017

BTGplc acquires Roxwood Medical

London, UK, 5 October 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Roxwood Medical (“Roxwood”), an innovative provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.

21 Aug 2017

BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme

BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology worldwide, have expanded their commitment to the Immuno-Oncology / Interventional Oncology research grant programme, by announcing a second round of funding available to investigators.

15 Feb 2017

BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology

BTG plc (LSE: BTG), the global specialist healthcare company, today announced a collaboration with the Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, to explore the role of interventional oncology alongside immuno-oncology

1 Apr 2016

BTG announces US launch of LC Bead LUMI™

First and only, commercially available, radiopaque embolic bead in the US has potential to revolutionize treatment of hypervascular tumors and arteriovenous malformations

3 Feb 2016

First Patient Treated With LC Bead LUMI Radiopaque Embolic Bead Supported by Philips Live Image Guidance

Collaboration brings new tools to interventional radiologists and oncologists to help treat liver cancer and enhanced patient care

14 Dec 2015

BTG announces FDA clearance for LC Bead LUMI, the first commercially available radiopaque embolic bead in the US

Unique LC Bead LUMI™ provides real-time visible confirmation of bead location during embolisation of hypervascular tumours and arteriovenous malformations

News & Events